Promising Role for Whole Genome Sequencing in Guiding Blood Cancer Treatment

Promising Role for Whole Genome Sequencing in Guiding Blood Cancer Treatment For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes. Some of these tests rely on